IMC:ASX
Immuron Ltd
၀.၀၃၇ A$
၀.၀၀%
(၀.၀၀) 1D
နို ၁၂, GMT+၁၁ ၁၂:၁၂:၀၀ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IMC...
Mkt. cap
၁.၁၉ ကုဋေ
Avg. vol.
၁.၁၂ သိန်း
Volume
၀.၀၀
52-wk high
၀.၀၇ A$
52-wk low
၀.၀၃ A$
EPS
-၀.၀၁ A$
Shares outstanding
၃၂.၂၈ ကုဋေ
No. of employees
၈
Mkt. cap
၁.၁၉ ကုဋေ
Avg. vol.
၁.၁၂ သိန်း
Volume
၀.၀၀
52-wk high
၀.၀၇ A$
52-wk low
၀.၀၃ A$
EPS
-၀.၀၁ A$
Shares outstanding
၃၂.၂၈ ကုဋေ
No. of employees
၈
News stories
From web sources and news partners
FOREX.com
·
ပြီးခဲ့သည့် ၄၄ မိနစ်
S&P 500 Quietly Shrugs Off the Bitcoin and Silver Selloff
Reuters
·
ပြီးခဲ့သည့် ၅၆ မိနစ်
UBS sees S&P 500 at 8,200 by end-2027 on earnings strength, resilient economy
BeInCrypto
·
ပြီးခဲ့သည့် ၂ နာရီ
How Deep Do S&P 500 Corrections Usually Go? Where 2026’s Drop Ranks
Profile
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
About Immuron Ltd
CEO-
Employees၈
Founded၁၉၉၄
HeadquartersBlackburn North, ဝိတိုရိယ ပြည်နယ်, ဩစတြေးလျ
SectorHealth Care
Industry-
Websiteimmuron.com.au